Literature DB >> 31282333

[Impacts of Different Nostril for Nasotracheal Intubation with Video Laryngoscopy].

Lei Wang1, Jing Hu Sui1, Xiao Ming Deng1, Wen Li Xu1, Ke Yu Chen1, Ling Xin Wei1, Dong Yang1.   

Abstract

Objective To compare the impacts of different nostril on nasotracheal intubation with video laryngoscopy.Methods Totally 120 ASA grade I maxillofacial surgery patients were equally randomized into two groups:group A(left nostril)and group B(right nostril).After rapid induction of anesthesia,the nasal intubation was completed by Tosight video laryngoscope,and the success rate of the first attempt of the tube passing through the nasal cavity was recorded and compared between these two groups.In addition,time of tube through nasal cavity,time of glottis exposure,total intubation time,intubation success rate,and nasal bleeding were recorded.Results The success rate of the first attempt of tube passing through the nasal cavity was not significantly different between groups A and B(84.7% vs. 81.7%;χ 2=0.202,P=0.653).The time of tube passing through nasal cavity [(7.3±4.6)s vs.(7.5±4.1)s;t=-0.223,P=0.824] and the time of glottic exposure [(6.6±1.4)s vs.(6.7±1.4)s;t=-0.348,P=0.728] had no significant differences between two groups.The success rates of first intubation attempt were 100% in both groups.The total intubation time was(35.1±9.2)s in group A and(34.0±7.8)s in group B(t=0.663,P=0.509).Intubation-related epistaxis was found in 16 cases(27.1%)in group A and in 17 cases(28.3%)in group B(χ 2 =0.022,P=0.882).Conclusion Different nasal approaches have no effect on nasal intubation.

Entities:  

Mesh:

Year:  2019        PMID: 31282333     DOI: 10.3881/j.issn.1000-503X.10982

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  1 in total

1.  An optimal tracheal tube preshaping strategy for endotracheal intubation using video laryngoscopy: a randomized controlled trial.

Authors:  Ya Cao; Lianxiang Jiang; Yan Zhang; Weidong Yao; Yongquan Chen; Zeping Dai
Journal:  J Clin Monit Comput       Date:  2022-01-27       Impact factor: 2.502

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.